Meropenem Injection, Powder, For Solution
Product Images NDC 44567-402

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 44567-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure of Meropenem showing its beta-lactam core and other characteristic functional groups. The structure includes a carboxylic acid, hydroxy group, and a sulfur atom in the ring, along with a dimethyl carbamoyl side chain and three water molecules of hydration (ยท3H2O).*
FDA Label Image

Meropenem 2 Gram Vial Label (Image 02)

Meropenem 2 Gram Vial Label (Image 02)
Meropenem for Injection USP 2 grams per vial injection powder for solution, intravenous route. The label indicates the product must be reconstituted and further diluted for infusion. Manufactured by WG Critical Care, LLC, this single-dose vial is made in Italy. Label includes dosage and storage instructions, NDC 44567-402-01, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.